Preclinical evaluation of performance, safety and usability of VAX-ID®, a novel intradermal injection device.

Beyers, Koen C L; Rbeihat, Momen N M; S Vasconcelos, Daniele; Pasmans, Danielle; Verwulgen, Stijn; Vankerckhoven, Vanessa V J

Beyers, Koen C L; Rbeihat, Momen N M; S Vasconcelos, Daniele; Pasmans, Danielle; Verwulgen, Stijn; Vankerckhoven, Vanessa V J.

Afiliación

Beyers KCL; Idevax BV, Wijnegem, Belgium. Electronic address: koen.beyers@idevax.com.
Rbeihat MNM; Idevax BV, Wijnegem, Belgium.
S Vasconcelos D; Idevax BV, Wijnegem, Belgium.
Pasmans D; Idevax BV, Wijnegem, Belgium.
Verwulgen S; Idevax BV, Wijnegem, Belgium; Center for evaluation of vaccination, University of Antwerp, Belgium.
Vankerckhoven VVJ; Idevax BV, Wijnegem, Belgium; Faculty of Design Sciences, Department of Product Development, University of Antwerp, Belgium.

Vaccine ; 41(31): 4609-4615, 2023 07 12.

Article en En | MEDLINE | ID: mdl-37330370

Asunto(s)

COVID-19; Vacunas; Animales; Porcinos; Inyecciones Intradérmicas/métodos; ARN Viral; COVID-19/prevención & control; SARS-CoV-2; Vacunación/métodos

Palabras clave

Device; Drug delivery; Intradermal injection; Performance; Usability; Vaccination

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Animals Idioma: En Revista: Vaccine Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google